MDT
Income statement / Annual
Last year (2025), Medtronic plc's total revenue was $33.54 B,
an increase of 3.62% from the previous year.
In 2025, Medtronic plc's net income was $4.66 B.
See Medtronic plc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
04/30/2025 |
04/30/2024 |
04/30/2023 |
04/30/2022 |
04/30/2021 |
04/30/2020 |
04/30/2019 |
04/30/2018 |
04/30/2017 |
04/30/2016 |
| Operating Revenue |
$33.54 B |
$32.36 B |
$31.23 B |
$31.69 B |
$30.12 B |
$28.91 B |
$30.56 B |
$29.95 B |
$29.71 B |
$28.83 B |
| Cost of Revenue |
$11.63 B
|
$11.22 B
|
$10.72 B
|
$10.15 B
|
$10.48 B
|
$9.42 B
|
$9.16 B
|
$9.07 B
|
$9.29 B
|
$9.14 B
|
| Gross Profit |
$21.91 B
|
$21.15 B
|
$20.51 B
|
$21.54 B
|
$19.63 B
|
$19.49 B
|
$21.40 B
|
$20.89 B
|
$20.42 B
|
$19.69 B
|
| Gross Profit Ratio |
0.65
|
0.65
|
0.66
|
0.68
|
0.65
|
0.67
|
0.7
|
0.7
|
0.69
|
0.68
|
| Research and Development Expenses |
$2.73 B
|
$2.74 B
|
$2.70 B
|
$2.75 B
|
$2.49 B
|
$2.33 B
|
$2.33 B
|
$2.26 B
|
$2.19 B
|
$2.22 B
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$10.85 B
|
$10.74 B
|
$10.42 B
|
$10.29 B
|
$10.15 B
|
$10.11 B
|
$10.42 B
|
$10.24 B
|
$10.02 B
|
$9.47 B
|
| Other Expenses |
$2.37 B
|
$2.53 B
|
$1.91 B
|
$2.75 B
|
$2.51 B
|
$2.26 B
|
$2.39 B
|
$1.75 B
|
$2.82 B
|
$2.64 B
|
| Operating Expenses |
$15.95 B
|
$16.00 B
|
$15.02 B
|
$15.79 B
|
$15.15 B
|
$14.70 B
|
$15.13 B
|
$14.25 B
|
$15.03 B
|
$14.33 B
|
| Cost And Expenses |
$27.58 B
|
$27.22 B
|
$25.74 B
|
$25.93 B
|
$25.63 B
|
$24.12 B
|
$24.29 B
|
$23.31 B
|
$24.33 B
|
$23.47 B
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$431.00 M
|
| Interest Expense |
$729.00 M
|
$719.00 M
|
$636.00 M
|
$553.00 M
|
$925.00 M
|
$1.09 B
|
$1.44 B
|
$1.15 B
|
$1.09 B
|
$1.39 B
|
| Depreciation & Amortization |
$2.86 B
|
$2.65 B
|
$2.70 B
|
$2.71 B
|
$2.70 B
|
$2.66 B
|
$2.66 B
|
$2.64 B
|
$2.92 B
|
$2.82 B
|
| EBITDA |
$9.22 B |
$8.20 B |
$8.70 B |
$8.78 B |
$7.52 B |
$7.81 B |
$9.30 B |
$9.47 B |
$8.61 B |
$8.54 B |
| EBITDA Ratio |
0.27
|
0.25
|
0.28
|
0.28
|
0.25
|
0.27
|
0.3
|
0.32
|
0.29
|
0.3
|
| Operating Income Ratio |
0.18
|
0.16
|
0.18
|
0.18
|
0.15
|
0.17
|
0.21
|
0.22
|
0.18
|
0.19
|
| Total Other Income/Expenses Net |
-$327.00 M
|
-$307.00 M
|
-$121.00 M
|
-$235.00 M
|
-$589.00 M
|
-$736.00 M
|
-$1.07 B
|
-$965.00 M
|
-$781.00 M
|
-$1.03 B
|
| Income Before Tax |
$5.63 B
|
$4.84 B
|
$5.36 B
|
$5.52 B
|
$3.90 B
|
$4.06 B
|
$5.20 B
|
$5.68 B
|
$4.60 B
|
$4.34 B
|
| Income Before Tax Ratio |
0.17
|
0.15
|
0.17
|
0.17
|
0.13
|
0.14
|
0.17
|
0.19
|
0.15
|
0.15
|
| Income Tax Expense |
$936.00 M
|
$1.13 B
|
$1.58 B
|
$456.00 M
|
$265.00 M
|
-$751.00 M
|
$547.00 M
|
$2.58 B
|
$578.00 M
|
$798.00 M
|
| Net Income |
$4.66 B
|
$3.68 B
|
$3.76 B
|
$5.04 B
|
$3.61 B
|
$4.79 B
|
$4.63 B
|
$3.10 B
|
$4.03 B
|
$3.54 B
|
| Net Income Ratio |
0.14
|
0.11
|
0.12
|
0.16
|
0.12
|
0.17
|
0.15
|
0.1
|
0.14
|
0.12
|
| EPS |
3.63 |
2.77 |
2.83 |
3.75 |
2.68 |
3.57 |
3.44 |
2.29 |
2.92 |
2.51 |
| EPS Diluted |
3.61 |
2.76 |
2.82 |
3.73 |
2.66 |
3.54 |
3.41 |
2.27 |
2.89 |
2.48 |
| Weighted Average Shares Out |
$1.29 B
|
$1.33 B
|
$1.33 B
|
$1.34 B
|
$1.34 B
|
$1.34 B
|
$1.35 B
|
$1.36 B
|
$1.38 B
|
$1.41 B
|
| Weighted Average Shares Out Diluted |
$1.29 B
|
$1.33 B
|
$1.33 B
|
$1.35 B
|
$1.35 B
|
$1.35 B
|
$1.36 B
|
$1.37 B
|
$1.39 B
|
$1.43 B
|
| Link |
|
|
|
|
|
|
|
|
|
|
